Why I think the Rolls-Royce share price is a FTSE 100 growth bargain

G A Chester is excited by the growth prospects of FTSE 100 (INDEXFTSE: UKX) aerospace giant Rolls-Royce Holding plc (LON:RR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Earnings at FTSE 100 aerospace giant Rolls-Royce (LSE: RR) finally pulled out of a steep three-year dive last year and they’re set to power higher. City analysts are forecasting annual increases in excess of 50% for each of the next two years.

I’ll come back shortly to why I view the stock as a top blue-chip growth buy. First, I’d like to tell you about mid-cap Synthomer (LSE: SYNT), which has been one of the FTSE 250‘s top-performing stocks of the last 10 years.

On track

Synthomer, which released a trading update this morning, provided its investors with an average return of 28% a year over the 10 years ended 31 December. And this year, the shares are up 14% so far, despite a 2% pullback in early trading today.

A speciality chemicals firm, Synthomer is one of the world’s leading suppliers of aqueous polymers. It serves customers in a wide range of industries, its polymers ending up in products as diverse as industrial flooring and medical examination gloves.

In today’s update, management reported that overall group performance in the first quarter of the year had been in line with its expectations. And it said its “full-year 2019 outlook remains unchanged.”

Still very buyable

City analysts are forecasting annual earnings growth of 5%-6%. At a share price of 405p, the price-to-earnings (P/E) ratio is 11.8 based on forecasts for the current year, falling to 11.1 on next year’s forecasts.

Add to the earnings growth a forecast dividend yield of 3.4%, rising to 3.6%, and you’ve got implied annual returns in high single-digits. The P/E is currently modest by the company’s historical standards, so there’s potential for higher returns, if the market decides to revert to a higher rating. The stock remains very buyable at the current price, I’d say.

Transformation

Rolls-Royce has come through a very difficult few years. Some of the challenges it faced were outside its control, but some can be laid at the door of previous management over a number of years.

When a company as big as Rolls-Royce has to undergo a major restructuring of its businesses, and change in its corporate culture, it takes time. I admire current chief executive Warren East, and the way he’s gone about the transformation, and I see similarities with Tesco boss Dave Lewis and the turnaround of the supermarket giant. Both men were able to hail a breakthrough year in delivering their latest annual results.

Top growth bargain

As you might expect for a company forecast to deliver earnings growth in excess of 50% this year and next, Rolls-Royce’s forward P/Es are significantly higher than Synthomer’s. At a share price of 915p, the aerospace group’s P/Es are 36 and 24.

However, due to the strength of the earnings growth, the price-to-earnings growth (PEG) ratio is highly attractive. Ratios of 0.6 for this year and 0.5 for next, are both deep on the good value side of the PEG fair value marker of 1.

For this reason, I see Rolls-Royce as a top FTSE 100 growth bargain. Meanwhile, its running dividend yield of 1.3% is only modest, but the payout can be expected to rise strongly in the coming years on the back of the anticipated impressive earnings growth.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Synthomer and Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »